1. Home
  2. XOMA vs LEGT Comparison

XOMA vs LEGT Comparison

Compare XOMA & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • LEGT
  • Stock Information
  • Founded
  • XOMA 1981
  • LEGT 2023
  • Country
  • XOMA United States
  • LEGT United States
  • Employees
  • XOMA N/A
  • LEGT N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • LEGT
  • Sector
  • XOMA Health Care
  • LEGT
  • Exchange
  • XOMA Nasdaq
  • LEGT Nasdaq
  • Market Cap
  • XOMA 300.5M
  • LEGT 274.3M
  • IPO Year
  • XOMA N/A
  • LEGT 2024
  • Fundamental
  • Price
  • XOMA $24.05
  • LEGT $10.65
  • Analyst Decision
  • XOMA Strong Buy
  • LEGT
  • Analyst Count
  • XOMA 2
  • LEGT 0
  • Target Price
  • XOMA $69.50
  • LEGT N/A
  • AVG Volume (30 Days)
  • XOMA 40.4K
  • LEGT 17.7K
  • Earning Date
  • XOMA 08-12-2025
  • LEGT 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • LEGT N/A
  • EPS Growth
  • XOMA N/A
  • LEGT N/A
  • EPS
  • XOMA N/A
  • LEGT 0.31
  • Revenue
  • XOMA $42,909,000.00
  • LEGT N/A
  • Revenue This Year
  • XOMA $70.91
  • LEGT N/A
  • Revenue Next Year
  • XOMA $14.00
  • LEGT N/A
  • P/E Ratio
  • XOMA N/A
  • LEGT $0.67
  • Revenue Growth
  • XOMA 638.41
  • LEGT N/A
  • 52 Week Low
  • XOMA $18.35
  • LEGT $10.10
  • 52 Week High
  • XOMA $35.00
  • LEGT $10.86
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 45.38
  • LEGT N/A
  • Support Level
  • XOMA $23.51
  • LEGT N/A
  • Resistance Level
  • XOMA $24.65
  • LEGT N/A
  • Average True Range (ATR)
  • XOMA 1.10
  • LEGT 0.00
  • MACD
  • XOMA -0.17
  • LEGT 0.00
  • Stochastic Oscillator
  • XOMA 20.92
  • LEGT 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

Share on Social Networks: